Liabilities / Assets
1st percentile
Higher debt load relative to assets than 1% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
-1.75x
Liabilities / Revenue
1st percentile
Higher debt load relative to revenue than 1% of similar nonprofits.
Net Margin
2nd percentile
Higher net margin than 2% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
5th percentile
Faster asset growth than 5% of similar nonprofits.
Revenue Growth
2nd percentile
Faster revenue growth than 2% of similar nonprofits.
Balance Sheet
Assets
Down$5,118
Down $12,576 (-71%) from 2018
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Down-$8,950
Down $18,401 (-195%) from 2018
Revenue And Expenses
Revenue
Down$3,932
Down $77,660 (-95%) from 2018
Expenses
Down$15,671
Down $38,556 (-71%) from 2018
Net Income
Down-$11,739
Down $39,104 (-143%) from 2018
Historical Trend
Filing Detail Status
This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2019 to Dec 31, 2019
Mission and Program Overview
Mission
Curable is a medical research accelerator whose mission is to expedite cures for rare disease by bringing individuals, academic institutions, government agencies and business together.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2019 • Form 990EZSummary only. Only limited summary data is available for this year.
- Assets
- $5,118
- Liabilities
- -$8,950
- Net assets
- -
- Revenue
- $3,932
- Expenses
- $15,671
- Net income
- -$11,739